Back to search
FDAFDA · Food and drugs·Recall number Z-0279-2025

AVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole blood oximeter.

Published November 6, 2024 · Recall initiated: September 27, 2024

Summary

FDA records medical device Class II recall Z-0279-2025, published November 6, 2024 and initiated September 27, 2024. Recalling firm: Accriva Diagnostics, Inc.; Status: Completed; Reported quantity: 1; Lot: UDI-DI: 10711234530023. Serial Number: 6824. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Values used to calibrate whole blood oximeter instruments were observed to be higher than normal, which may result in incorrect patient results where oxygen levels are higher than actual results, which may lead to patient care mismanagement requiring medical intervention.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Accriva Diagnostics, Inc.
Distributor
US: AZ
Lot
UDI-DI: 10711234530023. Serial Number: 6824
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was AVOXimeter 1000E, Product Number: AVOX1000E. The AVOXimeter 1000E is a battery-operated bedside whole blood oximeter. recalled?

Yes. FDA published recall Z-0279-2025 on November 6, 2024. Reported hazard: Values used to calibrate whole blood oximeter instruments were observed to be higher than normal, which may result in incorrect patient results where oxygen levels are higher than actual results, which may lead to patient care mismanagement requiring medical intervention.

What should I do if I have this product?

Voluntary: Firm initiated · Letter